Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin, Metformin, and Exercise in Pre-diabetes
NCT02695810Phase 2Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Feb 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dapagliflozin in prediabetes, sponsored by Steno Diabetes Center Copenhagen. Started Feb 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT02695810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695810.